Abstract:The development of CRISPR-based gene-editing technologies has brought an unprecedented revolution in the field of genome engineering. Cas12a, a member of the Class 2 Type V CRISPR-associated endonuclease family distinct from Cas9, has been repurposed and developed into versatile gene-editing tools with distinct PAM recognition sites and multiplexed gene targeting capability. However, with current CRISPR/Cas12a technologies, it remains a challenge to perform efficient and precise genome editing of long sequences in mammalian cells. To address this limitation, we utilized phage recombination enzymes and developed an efficient CRISPR/Cas12a tool for multiplexed precision editing in mammalian cells. Through protein engineering, we were able to recruit phage recombination proteins to Cas12a to enhance its homology-directed repair efficiencies. Our phage-recombination-assisted Cas12a system achieved up to 3-fold improvements for kilobase-scale knock-ins in human cells without compromising the specificity of the enzyme. The performance of this system compares favorably against Cas9 references, the commonly used enzyme for gene-editing tasks, with improved specificity. Additionally, we demonstrated multi-target editing with similar improved activities thanks to the RNA-processing activity of the Cas12a system. This compact, multi-target editing tool has the potential to assist in understanding multi-gene interactions. In particular, it paves the way for a gene therapy method for human diseases that complements existing tools and is suitable for polygenic disorders and diseases requiring long-sequence corrections.

Engineered IscB-ωRNA system with expanded target range for base editing

Development of miniature base editors using engineered IscB nickase

Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos

Engineering miniature IscB nickase for robust base editing with broad targeting range

Engineered domain-inlaid Nme2Cas9 adenine base editors with increased on-target DNA editing and targeting scope

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Engineering Nme2Cas9 Adenine Base Editors with Improved Activity and Targeting Scope

Engineered IscB-ωRNA system with improved base editing efficiency for disease correction via single AAV delivery in mice

Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e

Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors

Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

Design and application of the transformer base editor in mammalian cells and mice

Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing

Precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions

Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

Engineered DNase-inactive Cpf1 Variants to Improve Targeting Scope for Base Editing in E. Coli

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing